TY - JOUR
KW - health care provider
KW - Drug Monitoring
KW - antipsychotics
KW - Primary Health Care
KW - Risk Factors
KW - Empirical Study
KW - Quantitative Study
KW - Human
KW - Male
KW - Female
KW - Outpatient
KW - Childhood (birth-12 yrs)
KW - Preschool Age (2-5 yrs)
KW - School Age (6-12 yrs)
KW - Adolescence (13-17 yrs)
KW - Health Care Delivery
KW - Mental Health Services
KW - Physicians
KW - Pharmacy
KW - Neuroleptic Drugs
KW - monitoring
KW - Prescribing (Drugs)
KW - article
KW - US
KW - 3340:Clinical Psychopharmacology
AU - Elizabeth Shenkman
AU - Lindsay Thompson
AU - Regina Bussing
AU - Christopher B. Forrest
AU - Jennifer Woodard
AU - Yijun Sun
AU - Jasmine Mack
AU - Kamila B. Mistry
AU - Matthew J. Gurka
A1 - 
AD - Department of a Health Outcomes and Biomedical Informatics, University of Florida, Gainesville, FL, US eshenkman@ufl.edu; Department of Pediatrics, Institute for Child Health Policy, University of Florida, Gainesville, FL, US ; Department of Psychiatry, College of Medicine, University of Florida, Gainesville, FL, US ; Applied Clinical Research Center, Children’s Hospital of Philadelphia, Philadelphia, PA, US ; Agency for Healthcare Research and Quality, US Department of Health and Human Services, Rockville, MD, US ; Shenkman, Elizabeth,2004 Mowry Rd,Gainesville,US,32608,Department of Health Outcomes and Biomedical Informatics, Institute for Child Health Policy, College of Medicine, University of Florida,eshenkman@ufl.edu
BT - Pediatrics
C5 - Financing & Sustainability; Healthcare Disparities
CP - 1
DO - 10.1542/peds.2020-0658
IS - 1
JF - Pediatrics
LA - English
M1 - Journal Article
PY - 2021
SN - 0031-4005, 0031-4005
SP - 11
T1 - Provider specialty and receipt of metabolic monitoring for children taking antipsychotics
T2 - Pediatrics
TI - Provider specialty and receipt of metabolic monitoring for children taking antipsychotics
U1 - Financing & Sustainability; Healthcare Disparities
U3 - 10.1542/peds.2020-0658
VL - 147
VO - 0031-4005, 0031-4005
Y1 - 2021
Y2 - Jan 01
ER -